← FDA Drug Approvals (Drugs@FDA)
MIRABEGRON
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QILU · Approved 2025-06-30
Drug application
- FDA Application #
ANDA217989- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MIRABEGRON
- Generic name
- MIRABEGRON
- Active ingredients
- MIRABEGRON
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- QILU
- Manufacturer
- Qilu Pharmaceutical Co., Ltd.
- First approval
- 2025-06-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown